{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:21Z","timestamp":1790315061370,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1245\/s10434-018-6499-1","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T11:38:33Z","timestamp":1525261113000},"page":"2018-2026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival"],"prefix":"10.1245","volume":"25","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Sleightholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad G.","family":"Rusthoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"6499_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/oxfordjournals.aje.a009093","volume":"145","author":"B Price","year":"1997","unstructured":"Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145:211\u20138.","journal-title":"Am J Epidemiol."},{"key":"6499_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/10408440903044928","volume":"39","author":"B Price","year":"2009","unstructured":"Price B, Ware A.\u00a0Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39:576\u201388.","journal-title":"Crit Rev Toxicol."},{"key":"6499_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","volume":"20","author":"SH Moolgavkar","year":"2009","unstructured":"Moolgavkar SH, Meza R, Turim J.\u00a0Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005. Cancer Causes Control. 2009;20:935\u201344.","journal-title":"Cancer Causes Control."},{"key":"6499_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","volume":"19","author":"SJ Henley","year":"2013","unstructured":"Henley SJ, Larson TC, Wu M, et al.\u00a0Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003\u20132008. Int J Occup Environ Health. 2013;19:1\u201310.","journal-title":"Int J Occup Environ Health."},{"key":"6499_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jso.21167","volume":"99","author":"D Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez D, Cheung MC, Housri N, et al. Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol. 2009;99:51\u20137.","journal-title":"J Surg Oncol."},{"key":"6499_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/oem.51.12.804","volume":"51","author":"R Spirtas","year":"1994","unstructured":"Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51:804\u201311.","journal-title":"Occup Environ Med."},{"key":"6499_CR7","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, J\u00e4nne PA, et al. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol. 2008;26:3567\u201372.","journal-title":"J Clin Oncol."},{"key":"6499_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","volume":"13","author":"C Brigand","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F, et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006;13:405\u201312.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"TD Yan","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827\u201334.","journal-title":"Ann Oncol."},{"key":"6499_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Edwards G, Alderman R, Marquandt CE, Sugarbaker PH. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma\u2013a prospective study of 70 consecutive cases. Ann Surg Oncol. 2007;14:515\u201325.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR11","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"6499_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.ejso.2010.08.130","volume":"36","author":"D Baratti","year":"2010","unstructured":"Baratti D, Vaira M, Kusamura S, et al. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2010;36:1047\u201353.","journal-title":"Eur J Surg Oncol."},{"key":"6499_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/bjs.7263","volume":"98","author":"TC Chua","year":"2011","unstructured":"Chua TC, Yan TD, Deraco M, et al. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg. 2011;98:60\u20134.","journal-title":"Br J Surg."},{"key":"6499_CR14","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22:1686\u201393.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/annonc\/mdr301","volume":"23","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H. Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case\u2013control study. Ann Oncol. 2012;23:647\u201352.","journal-title":"Ann Oncol."},{"key":"6499_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1245\/s10434-011-1984-9","volume":"19","author":"YLB Klaver","year":"2012","unstructured":"Klaver YLB, Hendriks T, Lomme RMLM, et al. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study. Ann Surg Oncol. 2012;19:475\u201382.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/jgo.2016.01.05","volume":"7","author":"MD Goodman","year":"2016","unstructured":"Goodman MD, McPartland S, Detelich D, Saif MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol. 2016;7:45\u201357.","journal-title":"J Gastrointest Oncol."},{"key":"6499_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"K Bilimoria","year":"2008","unstructured":"Bilimoria K, Stewart A, Winchester D, Ko C. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683\u201390.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","volume":"12","author":"V Verma","year":"2017","unstructured":"Verma V, Ahern CA, Berlind CG, et al. National Cancer database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12:1704\u201314.","journal-title":"J Thorac Oncol."},{"key":"6499_CR20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-6293-5","author":"KI Votanopoulos","year":"2017","unstructured":"Votanopoulos KI, Sugarbaker P, Deraco M, et al. Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. Ann Surg Oncol. 2017; \n                    https:\/\/doi.org\/10.1245\/s10434-017-6293-5\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"key":"6499_CR21","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, et al. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49:3140\u20138.","journal-title":"Eur J Cancer."},{"key":"6499_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1200\/JOP.2016.011908","volume":"12","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Turaga KK, Alexander HR Jr, Deraco M, Hesdorffer M. Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy. J Oncol Pract. 2016;12:928\u201335.","journal-title":"J Oncol Pract."},{"key":"6499_CR23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan TD, Deraco M, Elias D, et al. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer. 2011;117:1855\u201363.","journal-title":"Cancer."},{"key":"6499_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","volume":"20","author":"NP Schaub","year":"2013","unstructured":"Schaub NP, Alimchandani M, Quezado M, et al. A novel nomogram for\u00a0peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013;20:555\u201361.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","volume":"23","author":"S Kusamura","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2016;23:1468\u201373.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR26","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"6499_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jso.23276","volume":"107","author":"YJ McConnell","year":"2013","unstructured":"McConnell YJ, Mack LA, Francis WP, et al.\u00a0HIPEC\u2009\u00a0+\u00a0\u2009EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol. 2013;107:591\u20136.","journal-title":"J Surg Oncol."},{"key":"6499_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.amjsurg.2015.03.008","volume":"210","author":"JY Lam","year":"2015","unstructured":"Lam JY, McConnell YJ, Rivard JD, et al.\u00a0Hyperthermic intraperitoneal chemotherapy\u2009+\u2009early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis. Am J Surg. 2015;210:424\u201330.","journal-title":"Am J Surg."},{"key":"6499_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","volume":"65","author":"V Kepenekian","year":"2016","unstructured":"Kepenekian V, Elias D, Passot G, et al.\u00a0Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE database: multi-institutional retrospective study. Eur J Cancer. 2016;65:69\u201379.","journal-title":"Eur J Cancer."},{"key":"6499_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1245\/s10434-016-5529-0","volume":"24","author":"Y Huang","year":"2017","unstructured":"Huang Y, Alzahrani NA, Liauw W, et al. Early postoperative intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasms with pseudomyxoma peritonei: is it beneficial? Ann Surg Oncol. 2017;24:176\u201383.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","volume":"43","author":"PH Sugarbaker","year":"2017","unstructured":"Sugarbaker PH, Chang D. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Eur J Surg Oncol. 2017;43:1228\u201335.","journal-title":"Eur J Surg Oncol."},{"key":"6499_CR32","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1245\/s10434-017-6033-x","volume":"24","author":"F Roy Le","year":"2017","unstructured":"Le Roy F, Gelli M, Hollebecque A, et al. Conversion to complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant\u00a0peritoneal mesothelioma\u00a0after bidirectional chemotherapy. Ann Surg Oncol. 2017;24:3640\u20136.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ejso.2010.07.001","volume":"36","author":"MD Kluger","year":"2010","unstructured":"Kluger MD, Taub RN, Hersdorffer M, Jin Z, Chabot JA. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: operative morbidity and mortality in phase I and II trials. Eur J Surg Oncol. 2010;36:997\u20131003.","journal-title":"Eur J Surg Oncol."},{"key":"6499_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2782590","author":"R Shavelle","year":"2017","unstructured":"Shavelle R, Vavra-Musser K, Lee J, Brooks J. Life expectancy in pleural and peritoneal mesothelioma. Lung Cancer Int. 2017; \n                    https:\/\/doi.org\/10.1155\/2017\/2782590\n                    \n                  .","journal-title":"Lung Cancer Int."},{"key":"6499_CR35","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560\u20137.","journal-title":"J Clin Oncol."},{"key":"6499_CR36","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge D, Zenati MS, Austin F, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159\u201365.","journal-title":"Ann Surg Oncol."},{"key":"6499_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canep.2017.10.008","volume":"51","author":"SAS Salo","year":"2017","unstructured":"Salo SAS, Ilonen I, Laaksonen S, et al. Epidemiology of malignant peritoneal mesothelioma: a population-based study. Cancer Epidemiol. 2017;51:81\u20136.","journal-title":"Cancer Epidemiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6499-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:42:09Z","timestamp":1581943329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["6499"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6499-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}